Technetium-99m-methylene diphosphonate uptake in the fetal skeleton at 30 weeks gestation.
Retention of 99mTc-MDP in the fetal skeleton and placenta at 30 and 32 wk gestation was observed during bone scan examination of the maternal skeleton for staging of malignant tumors. The implications and significance of these observations are discussed.
McKenzie
A F
AF
Department of Diagnostic Imaging, Peter MacCallum Cancer Institute, Melbourne, Australia.
Budd
R S
RS
Yang
C
C
Shapiro
B
B
Hicks
R J
RJ
D000328:Adult; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology; D005260:Female; D005333:Fetus / Q000000981:diagnostic imaging* / Q000528:radiation effects; D005865:Gestational Age; D018212:Giant Cell Tumor of Bone / Q000000981:diagnostic imaging*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010920:Placenta / Q000000981:diagnostic imaging; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000000981:diagnostic imaging*; D011829:Radiation Dosage; D011877:Radionuclide Imaging; D013669:Technetium Tc 99m Medronate; D013977:Tibia / Q000000981:diagnostic imaging
D013669:Technetium Tc 99m Medronate